These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2641790)

  • 1. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
    Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
    J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY; Staren ED; Tereshkova N; Braun DP
    J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
    Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
    Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic effector cells in head and neck cancer.
    Vitolo D; Letessier EM; Johnson JT; Whiteside TL
    J Natl Cancer Inst Monogr; 1992; (13):203-8. PubMed ID: 1356393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
    Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity.
    Murali PS; Somasundaram R; Rao RS; Fakih AR; Gangal SG
    J Oral Pathol Med; 1989 Jul; 18(6):327-32. PubMed ID: 2810131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
    Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
    Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
    Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
    Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer and lymphokine-activated killer cell-mediated cytotoxicity in patients with oral cancer.
    Gangal SG; Tatake RJ; Krishnan N; Mukhopadhyaya R; Naik SL; Fakih AR; Rao RS
    Semin Surg Oncol; 1989; 5(5):347-50. PubMed ID: 2814145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH
    Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer-cell-mediated and antibody-dependent cellular cytotoxicity in leprosy.
    Chiplunkar SV; Deshmukh MV; Samson PD; Butlin R; Bhatki WS; Chulawalla RG; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):334-41. PubMed ID: 2376683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer.
    Sakakura K; Chikamatsu K; Sakurai T; Takahashi K; Murata T; Oriuchi N; Furuya N
    Oral Oncol; 2005 Jan; 41(1):89-96. PubMed ID: 15598591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of tumor-associated blastogenic reactivity of peripheral blood lymphocytes and regional lymph node lymphocytes in human malignancy.
    Kurosu Y; Saegusa Y; Tominaga M; Morita K
    Jpn J Clin Oncol; 1983 Mar; 13(1):25-30. PubMed ID: 6834651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.